Founded in 2012, Desktop Genetics is a London-based company that offers a CRISPR research tool to help researchers plan genome-editing techniques via their computer. A network of partner companies can help the researcher conduct their experiments. Eventually, the company told MD+DI, it hopes to develop AI technology for personalized genome editing therapies for patients.

The company is working with Imperial College London's Epigenetics Unit to study the epigentics behind chemotherapy resistance in ovarian cancer. Desktop Genetics has received investment funding from Illumina and counts Editas Medicine among its users. 

Desktop Genetics was named a 2016 SXSW Interactive Innovation Award winner in the category of Health, Med, and Biotech and was also one of eight finalists in the Health and Wearable Technologies category of the SXSW Accelerator pitch competition.

Get inspired to innovate during Massachusetts Medtech Week—register for BIOMEDevice Boston 2016, April 13-14.